4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-19-053665
Director bought 1,000,000 shares at $20.00 ($20,000,000)
- Director acquired 27,222,219 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT Director | 2019-10-16 | Conversion | +11,666,665 | 12,111,109 | I: show line 1 in the form | ||
| NELSEN ROBERT Director | 2019-10-16 | Conversion | +15,555,554 | 15,555,554 | I: show line 2 in the form | ||
| NELSEN ROBERT Director | 2019-10-16 | Purchase | +1,000,000 | $20.00 | $20,000,000 | 1,000,000 | I: show line 3 in the form |
| Open-market purchases · 1,000,000 sh · avg $20.00 · $20,000,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NELSEN ROBERT Director | 2019-10-16 | Conversion · Series A-1 Convertible Preferred Stock | −11,111,110 | 0 | I: show line 4 in the form | |||||
| NELSEN ROBERT Director | 2019-10-16 | Conversion · Series A-1 Convertible Preferred Stock | −13,333,332 | 0 | I: show line 5 in the form | |||||
| NELSEN ROBERT Director | 2019-10-16 | Conversion · Series B Convertible Preferred Stock | −555,555 | 0 | I: show line 6 in the form | |||||
| NELSEN ROBERT Director | 2019-10-16 | Conversion · Series B Convertible Preferred Stock | −2,222,222 | 0 | I: show line 7 in the form |
Loading xslF345X03/doc4.xml…